Metraipolis › archive › dc_f3f99326e2bc

Pharmacological HIF activation protects against diet-induced obesity, glucose intolerance, and skeletal dysfunction by exerting dual beneficial effects on… — Europe PMC PMID:41667436

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41667436
DOI
10.1038/s41413-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-05T23:03:56.794Z
SHA-256 of the archived text
ef9636f42e7783d5db926aa016da5f315b7dbd2dc98fb2a4579e38ec537fca5e
Stable URL of this page
https://metraipolis.com/documento/dc_f3f99326e2bc

How to cite

Pharmacological HIF activation protects against diet-induced obesity, glucose intolerance, and skeletal dysfunction by exerting dual beneficial effects on… — Europe PMC PMID:41667436 — Europe PMC (en), https://europepmc.org/article/MED/41667436 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f3f99326e2bc (Metraipolis archive dc_f3f99326e2bc, sha256 ef9636f42e7783d5db926aa016da5f315b7dbd2dc98fb2a4579e38ec537fca5e)
BibTeX
@misc{dcf3f99326e2bc,
  title = {Pharmacological HIF activation protects against diet-induced obesity, glucose intolerance, and skeletal dysfunction by exerting dual beneficial effects on… — Europe PMC PMID:41667436},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41667436},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f3f99326e2bc; sha256 ef9636f42e7783d5db926aa016da5f315b7dbd2dc98fb2a4579e38ec537fca5e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41667436. Agents can read the archived copy with the MCP tool read_document.